Patent details

EP1877099 Title: THERAPEUTIC CONJUGATES COMPRISING A LYSOSOMAL ENZYME, POLYSIALIC ACID AND A TARGETING MOIETY

Basic Information

Publication number:
EP1877099
PCT Application Number:
PCT/US/2006/012698
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP067405720
PCT Publication Number:
WO/2006/108052
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THERAPEUTIC CONJUGATES COMPRISING A LYSOSOMAL ENZYME, POLYSIALIC ACID AND A TARGETING MOIETY
French Title of Invention:
CONJUGUÉS THÉRAPEUTIQUES COMPRENANT UNE ENZYME LYSOSOMALE, L'ACIDE POLYSIALIQUE ET UN AGENT DE CIBLAGE
German Title of Invention:
THERAPEUTISCHE KONJUGATE BEINHALTEND EIN LYSOSOMALES ENZYM, POLYSIALINSÄURE UND EINE ZIELKOMPONENTE
SPC Number:

Dates

Filing date:
05/04/2006
Grant date:
19/09/2012
EP Publication Date:
19/09/2012
PCT Publication Date:
12/10/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/01/2008
EP B1 Publication Date:
19/09/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/04/2013
Expiration date:
05/04/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/04/2006
 
 

Name:
GENZYME CORPORATION
Address:
500 Kendall Street, Cambridge, MA 02142, United States (US)

Inventor

Name:
STEFANO James
Address:
United States (US)

Priority

Priority Number:
668920 P
Priority Date:
06/04/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 47/48;
Filing date Document type Number of pages